Skip to main content

More Treatments for All People More Quickly

We conduct research and support activities that address long-standing challenges in translational research so that new treatments and other health solutions reach people faster.

Latest News

Read our latest research news or follow coverage of our translational science activities through national and local media.

Spectradyne: SBIR Funding Spurs Advances in Nanoparticle Technology

November 19, 2024 - NCATS News

  • Small Business (SBIR)

NCATS small business innovation research funding helped Spectradyne, LLC, commercialize an improved nanoparticle analyzer critical to research and drug development.

Easing the Burden of Rare Diseases Through Translational Science

November 12, 2024 - NCATS News

  • Our Impact on Rare Diseases

NCATS Director Joni Rutter discusses how NCATS is addressing scientific and operational roadblocks that slow progress for rare diseases research and treatments.

New FDA Designations May Jumpstart Gene Therapy Development

October 18, 2024 - NCATS News

  • Bespoke Gene Therapy Consortium (BGTC)
  • Platform Vector Gene Therapy (PaVe-GT)

New FDA designations granted to NCATS for rare disease therapies provide financial incentives for companies to further develop treatments.


Advancing Translational Science

Our Impact

Learn how our work speeds research and improves health. Key areas include big data, clinical trials and rare diseases.

Research Activities

Explore our research labs, projects and collaborations that are advancing translational science. Our largest program is the Clinical and Translational Science Awards (CTSA) Program.

Training & Education

Enhance your knowledge of translational science through programs, activities and resources offered by NCATS and our partner institutions.


Resources for You

Whether you're a researcher, an aspiring translational scientist or an interested member of the community, find information and materials important to you.


Director's Corner

Joni L. Rutter, Ph.D.

Director's Message

Easing the Burden of Rare Diseases Through Translational Science

November 12, 2024

NCATS Director Joni Rutter kicks off a new message series on progress and priorities in rare diseases research across the translational pipeline.

About the NCATS Director

Joni L. Rutter, Ph.D., is the director of NCATS at NIH. Rutter oversees the planning and execution of NCATS complex, multifaceted programs.

Previous Director's Messages

Search all Director's Messages by topic and year.

Subscribe to NCATS’ Community Update

Sign up to receive email messages from Dr. Rutter on center initiatives, input opportunities, events and other activities.

Last updated on November 12, 2024